Susquehanna International Group, LLP Reviva Pharmaceuticals Holdings, Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 231,450 shares of RVPH stock, worth $87,951. This represents 0.0% of its overall portfolio holdings.
Number of Shares
231,450
Previous 202,012
14.57%
Holding current value
$87,951
Previous $349,000
37.25%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding RVPH
# of Institutions
56Shares Held
7.42MCall Options Held
938KPut Options Held
62.1K-
Vanguard Group Inc Valley Forge, PA1.8MShares$685,5540.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.53MShares$583,0400.0% of portfolio
-
Diadema Partners LP Morristown, NJ651KShares$247,2740.16% of portfolio
-
Tang Capital Management LLC San Diego, CA510KShares$193,9250.03% of portfolio
-
Geode Capital Management, LLC Boston, MA419KShares$159,2720.0% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $7.77M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...